• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科肾移植受者的非免疫性同种异体移植物丢失。

Non-immunologic allograft loss in pediatric kidney transplant recipients.

机构信息

Division of Nephrology, LSU Health New Orleans and Children's Hospital, 200 Henry Clay Avenue, New Orleans, LA, 70130, USA.

Washington University and St. Louis Children's Hospital, 600 South Euclid Ave, St. Louis, MO, 63110, USA.

出版信息

Pediatr Nephrol. 2019 Feb;34(2):211-222. doi: 10.1007/s00467-018-3908-4. Epub 2018 Feb 26.

DOI:10.1007/s00467-018-3908-4
PMID:29480356
Abstract

Non-immunologic risk factors are a major obstacle to realizing long-term improvements in kidney allograft survival. A standardized approach to assess donor quality has recently been introduced with the new kidney allocation system in the USA. Delayed graft function and surgical complications are important risk factors for both short- and long-term graft loss. Disease recurrence in the allograft remains a major cause of graft loss in those who fail to respond to therapy. Complications of over immunosuppression including opportunistic infections and malignancy continue to limit graft survival. Alternative immunosuppression strategies are under investigation to limit calcineurin inhibitor toxicity. Finally, recent studies have confirmed long-standing observations of the significant negative impact of a high-risk age window in late adolescence and young adulthood on long-term allograft survival.

摘要

非免疫因素是实现肾移植长期存活率提高的主要障碍。美国新的肾脏分配系统最近引入了一种评估供体质量的标准化方法。延迟移植物功能和手术并发症是短期和长期移植物丢失的重要危险因素。在那些对治疗无反应的患者中,移植物疾病复发仍然是移植物丢失的主要原因。过度免疫抑制的并发症,包括机会性感染和恶性肿瘤,继续限制移植物的存活。正在研究替代免疫抑制策略来限制钙调神经磷酸酶抑制剂的毒性。最后,最近的研究证实了长期以来的观察结果,即青春期后期和成年早期的高风险年龄窗口对长期移植物存活有显著的负面影响。

相似文献

1
Non-immunologic allograft loss in pediatric kidney transplant recipients.儿科肾移植受者的非免疫性同种异体移植物丢失。
Pediatr Nephrol. 2019 Feb;34(2):211-222. doi: 10.1007/s00467-018-3908-4. Epub 2018 Feb 26.
2
Effect of BMI on allograft function and survival in pediatric renal transplant recipients.BMI 对儿童肾移植受者移植物功能和存活的影响。
Pediatr Nephrol. 2018 Aug;33(8):1429-1435. doi: 10.1007/s00467-018-3942-2. Epub 2018 Mar 25.
3
Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.肾素-血管紧张素系统阻断及避免大剂量使用钙调神经磷酸酶抑制剂可预防肾移植受者的间质纤维化和肾小管萎缩。
Exp Clin Transplant. 2017 Feb;15(Suppl 1):32-36. doi: 10.6002/ect.mesot2016.O19.
4
Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.慢性移植肾功能不全的肾移植受者长期移植肾失功的危险因素。
Exp Clin Transplant. 2010 Dec;8(4):277-82.
5
Effects of different trends on the development and outcome of early kidney allograft dysfunction.不同趋势对早期肾移植功能障碍的发展及结局的影响
Exp Clin Transplant. 2015 Apr;13 Suppl 1:228-30.
6
Causes of late transplant failure in cyclosporine-treated kidney allograft recipients.环孢素治疗的肾移植受者晚期移植失败的原因。
Clin Exp Nephrol. 2019 Aug;23(8):1076-1086. doi: 10.1007/s10157-019-01740-7. Epub 2019 Apr 23.
7
[Identifying the specific causes of kidney allograft loss: A population-based study].[确定肾移植受者失肾的具体原因:一项基于人群的研究]
Nephrol Ther. 2018 Apr;14 Suppl 1:S39-S50. doi: 10.1016/j.nephro.2018.02.018.
8
Calcineurin Inhibitor-Sparing Strategies in Renal Transplantation: Where Are We? A Comprehensive Review of the Current Evidence.肾移植中钙调神经磷酸酶抑制剂节约策略:我们目前的进展如何?对当前证据的全面综述
Exp Clin Transplant. 2016 Oct;14(5):471-483. doi: 10.6002/ect.2015.0283. Epub 2015 May 17.
9
Why hasn't eliminating acute rejection improved graft survival?为什么消除急性排斥反应并没有提高移植物存活率?
Annu Rev Med. 2007;58:369-85. doi: 10.1146/annurev.med.58.061705.145143.
10
CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.肾移植后淋巴组织增生性疾病停用钙调神经磷酸酶抑制剂是移植物失功和死亡的独立危险因素。
Transpl Int. 2014 Sep;27(9):956-65. doi: 10.1111/tri.12375. Epub 2014 Aug 20.

引用本文的文献

1
Language barriers and kidney transplantation in children.儿童肾移植中的语言障碍。
Pediatr Nephrol. 2023 Jul;38(7):2209-2219. doi: 10.1007/s00467-022-05821-w. Epub 2022 Dec 12.
2
Emerging monitoring technologies in kidney transplantation.肾移植中的新兴监测技术。
Pediatr Nephrol. 2021 Oct;36(10):3077-3087. doi: 10.1007/s00467-021-04929-9. Epub 2021 Feb 1.

本文引用的文献

1
Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients.儿童实体器官移植受者高血糖和糖尿病的发生率及与电解质异常的关系。
Nephrol Dial Transplant. 2017 Sep 1;32(9):1579-1586. doi: 10.1093/ndt/gfx205.
2
Graft outcomes following diagnosis of post-transplant lymphoproliferative disease in pediatric kidney recipients: a retrospective study.移植后淋巴组织增生性疾病诊断后儿科肾移植受者的移植物结局:一项回顾性研究。
Transpl Int. 2018 Apr;31(4):367-376. doi: 10.1111/tri.13071. Epub 2017 Oct 11.
3
Body mass index as a predictor of outcomes among pediatric kidney transplant recipient.
体重指数作为小儿肾移植受者预后的预测指标。
Pediatr Transplant. 2017 Sep;21(6). doi: 10.1111/petr.12992. Epub 2017 Jun 13.
4
Obesity in pediatric kidney transplant recipients and the risks of acute rejection, graft loss and death.小儿肾移植受者的肥胖与急性排斥反应、移植物丢失及死亡风险
Pediatr Nephrol. 2017 Aug;32(8):1443-1450. doi: 10.1007/s00467-017-3636-1. Epub 2017 Mar 30.
5
Outcomes and Risk Factors for Graft Loss: Lessons Learned from 1,056 Pediatric Kidney Transplants at the University of Minnesota.移植肾失功的结局与危险因素:明尼苏达大学1056例小儿肾移植的经验教训
J Am Coll Surg. 2017 Apr;224(4):473-486. doi: 10.1016/j.jamcollsurg.2016.12.027. Epub 2017 Feb 27.
6
En bloc kidney transplantation from infant donors younger than 10 months into pediatric recipients.将10个月以下婴儿供体的肾脏整体移植给小儿受体。
Pediatr Transplant. 2017 Mar;21(2). doi: 10.1111/petr.12845. Epub 2017 Jan 1.
7
Hypomagnesemia and increased risk of new-onset diabetes mellitus after transplantation in pediatric renal transplant recipients.小儿肾移植受者移植后低镁血症与新发糖尿病风险增加
Pediatr Nephrol. 2017 May;32(5):879-884. doi: 10.1007/s00467-016-3571-6. Epub 2016 Dec 30.
8
Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.将载脂蛋白L1(APOL1)基因变异纳入肾移植:美国移植学会专家会议引发的思考
Am J Transplant. 2017 Apr;17(4):901-911. doi: 10.1111/ajt.14173. Epub 2017 Feb 2.
9
Risk Factors for Graft Loss in Pediatric Renal Transplant Recipients After Transfer of Care.护理转移后小儿肾移植受者移植物丢失的危险因素。
Prog Transplant. 2016 Dec;26(4):356-364. doi: 10.1177/1526924816667952. Epub 2016 Sep 28.
10
Prediction, prevention, and management of delayed graft function: where are we now?移植肾功能延迟恢复的预测、预防及处理:我们目前处于什么阶段?
Clin Transplant. 2016 Oct;30(10):1198-1208. doi: 10.1111/ctr.12832. Epub 2016 Sep 12.